Heron Therapeutics Inc. (HRTX) Has Jumped To A New High On FDA Designation

Heron Therapeutics Inc. (HRTX) announced Thursday morning that it has received Breakthrough Therapy designation from the FDA for HTX-011, for postoperative pain management.

from RTT - Hot Stocks https://ift.tt/2JXOSU2
via IFTTT